- Home
- MITT vs EPIX Comparison
MITT vs EPIX Comparison
Compare MITT & EPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MITT
- EPIX
- Stock Information
- Founded
- MITT 2011
- EPIX 2009
- Country
- MITT United States
- EPIX Canada
- Employees
- MITT N/A
- EPIX N/A
- Industry
- MITT Real Estate Investment Trusts
- EPIX Biotechnology: Pharmaceutical Preparations
- Sector
- MITT Real Estate
- EPIX Health Care
- Exchange
- MITT Nasdaq
- EPIX Nasdaq
- Market Cap
- MITT 199.8M
- EPIX 209.4M
- IPO Year
- MITT 2011
- EPIX N/A
- Fundamental
- Price
- MITT $6.78
- EPIX $1.72
- Analyst Decision
- MITT Strong Buy
- EPIX Hold
- Analyst Count
- MITT 5
- EPIX 4
- Target Price
- MITT $8.00
- EPIX $9.50
- AVG Volume (30 Days)
- MITT 193.9K
- EPIX 2.4M
- Earning Date
- MITT 11-05-2024
- EPIX 12-10-2024
- Dividend Yield
- MITT 11.23%
- EPIX N/A
- EPS Growth
- MITT 269.43
- EPIX N/A
- EPS
- MITT 2.09
- EPIX N/A
- Revenue
- MITT $80,741,000.00
- EPIX N/A
- Revenue This Year
- MITT N/A
- EPIX N/A
- Revenue Next Year
- MITT $14.66
- EPIX N/A
- P/E Ratio
- MITT $3.24
- EPIX N/A
- Revenue Growth
- MITT 17.98
- EPIX N/A
- 52 Week Low
- MITT $5.09
- EPIX $1.40
- 52 Week High
- MITT $7.95
- EPIX $11.67
- Technical
- Relative Strength Index (RSI)
- MITT 33.68
- EPIX 23.15
- Support Level
- MITT $6.79
- EPIX $1.75
- Resistance Level
- MITT $7.16
- EPIX $1.89
- Average True Range (ATR)
- MITT 0.20
- EPIX 0.19
- MACD
- MITT -0.03
- EPIX -0.10
- Stochastic Oscillator
- MITT 9.03
- EPIX 7.36
About MITT AG Mortgage Investment Trust Inc.
AG Mortgage Investment Trust Inc is a real estate investment trust (REIT). It focuses on investing in a diversified risk-adjusted portfolio of residential mortgage-related assets in the U.S. mortgage market. Its objective is to provide attractive risk-adjusted returns to its stockholders over the long-term through dividends and capital appreciation. It also focuses on investing in residential mortgage-backed securities (RMBS) issued or guaranteed by a government sponsored enterprise.
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company is focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.